Department of Biochemistry and Molecular Biology, Faculty of Optics and Optometry, Universidad Complutense de Madrid, C/Arcos de Jalon 118, Madrid 28037, Spain.
Functional Proteomics Unit, Chronic Disease Programme (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Curr Med Chem. 2020;27(27):4549-4566. doi: 10.2174/0929867326666190627131300.
The eye is a complex organ comprised of several compartments with exclusive and specialized properties that reflect their diverse functions. Although the prevalence of eye pathologies is increasing, mainly because of its correlation with aging and of generalized lifestyle changes, the pathogenic molecular mechanisms of many common ocular diseases remain poorly understood. Therefore, there is an unmet need to delve into the pathogenesis, diagnosis, and treatment of eye diseases to preserve ocular health and reduce the incidence of visual impairment or blindness. Proteomics analysis stands as a valuable tool for deciphering protein profiles related to specific ocular conditions. In turn, such profiles can lead to real breakthroughs in the fields of ocular science and ophthalmology. Among proteomics techniques, protein microarray technology stands out by providing expanded information using very small volumes of samples. In this review, we present a brief summary of the main types of protein microarrays and their application for the identification of protein changes in chronic ocular diseases such as dry eye, glaucoma, age-related macular degeneration, or diabetic retinopathy. The validation of these specific protein alterations could provide new biomarkers, disclose eye diseases pathways, and help in the diagnosis and development of novel therapies for eye pathologies.
眼睛是一个由几个具有独特和专门特性的腔室组成的复杂器官,这些特性反映了它们多样化的功能。尽管眼部疾病的发病率正在上升,主要是因为它与衰老和普遍的生活方式改变有关,但许多常见眼部疾病的发病分子机制仍知之甚少。因此,需要深入研究眼部疾病的发病机制、诊断和治疗方法,以维护眼部健康,降低视力损害或失明的发生率。蛋白质组学分析是解析与特定眼部疾病相关的蛋白质谱的一种有价值的工具。反过来,这些图谱可以为眼科学和眼科领域带来真正的突破。在蛋白质组学技术中,蛋白质微阵列技术通过使用非常少量的样本提供扩展信息而脱颖而出。在这篇综述中,我们简要总结了主要类型的蛋白质微阵列及其在识别干眼症、青光眼、年龄相关性黄斑变性或糖尿病性视网膜病变等慢性眼部疾病中的蛋白质变化方面的应用。对这些特定蛋白质变化的验证可以提供新的生物标志物,揭示眼部疾病的途径,并有助于眼部疾病的诊断和新型疗法的开发。